Skip to main content

Shkrelli: What's his status nowadays

Martin Shkreli 2016.jpg

I  recently read an article about the cancellation of a planned appearance at UC Davis of alt-right provocateur Milo Yiannopoulos and Martin Shkreli.  Seems like a classic instance of "heckler's veto."

 I don't care about MY especially. The references to MS in this story piqued my interest, though.

You may remember that Shkreli, pictured above, was formerly a pharmaceutical CEO, accused of jacking up prices of life-saving drugs unconscionably and of committing securities fraud in the process. He was arrested by the FBI a little more than a year ago, December 2015.

It struck me when I heard about this UC Davis thing that it has been a long time since I had heard anything more about the proceedings. I gather he has been out on bail pending trial ever since. But this seems like a fairly long time to pass without any news.

There once was a time, not long ago, when I would have been following the case in detail, and I'd know about discovery motions, evidentiary exclusion issues and other pretrial stuff. But the focus of my own professional (and personal) concerns has shifted and I have no idea. I didn't even know until I started work on this blog post the district in which he had been indicted.

By way of penance (?), I've looked into it.  He was indicted in the Eastern District of New York, in Brooklyn. In recent days the judge in charge of the matter approved a motion allowing the defendant to travel to Washington DC for inaugural festivities. That seems oddly permissive to me for someone who had to post a $5 million bond to remain at large at all.

There is a trial date: June 26.

That's enough to satisfy my curiosity for now. I'll come back to it to look at discovery issues some other time.

Comments

Popular posts from this blog

Cancer Breakthrough

Hopeful news in recent days about an old and dear desideratum: a cure for cancer. Or at least for a cancer, and a nasty one at that.

The news comes about because investors in GlaxoSmithKline are greedy for profits, and has already inspired a bit of deregulation to boot. 

The FDA has paved the road for a speedy review of a new BCMA drug for multiple myeloma, essentially cancer of the bone marrow. This means that the US govt has removed some of the hurdles that would otherwise (by decision of the same govt) face a company trying to proceed with these trials expeditiously. 

This has been done because the Phase I clinical trial results have been very promising. The report I've seen indicates that details of these results will be shared with the world on Dec. 11 at the annual meeting of the American Society of Hematology. 

The European Medicines Agency has also given priority treatment to the drug in question. 

GSK's website identifies the drug at issue as "GSK2857916," althou…

A Story About Coleridge

This is a quote from a memoir by Dorothy Wordsworth, reflecting on a trip she took with two famous poets, her brother, William Wordsworth, and their similarly gifted companion, Samuel Taylor Coleridge.



We sat upon a bench, placed for the sake of one of these views, whence we looked down upon the waterfall, and over the open country ... A lady and gentleman, more expeditious tourists than ourselves, came to the spot; they left us at the seat, and we found them again at another station above the Falls. Coleridge, who is always good-natured enough to enter into conversation with anybody whom he meets in his way, began to talk with the gentleman, who observed that it was a majestic waterfall. Coleridge was delighted with the accuracy of the epithet, particularly as he had been settling in his own mind the precise meaning of the words grand, majestic, sublime, etc., and had discussed the subject with William at some length the day before. “Yes, sir,” says Coleridge, “it is a majestic wate…

Hume's Cutlery

David Hume is renowned for two pieces of cutlery, the guillotine and the fork.

Hume's guillotine is the sharp cut he makes between "is" statements and "ought" statements, to make the point that the former never ground the latter.

His "fork" is the division between what later came to be called "analytic" and "synthetic" statements, with the ominous observation that any books containing statements that cannot be assigned to one or the other prong should be burnt.

Actually, I should acknowledge that there is some dispute as to how well or poorly the dichotomy Hume outlines really maps onto the analytic/synthetic dichotomy. Some writers maintain that Hume meant something quite different and has been hijacked. Personally, I've never seen the alleged difference however hard they've worked to point it out to me.

The guillotine makes for a more dramatic graphic than a mere fork, hence the bit of clip art above.

I'm curious whe…